Barclays Lowers Integral Ad Science (NASDAQ:IAS) Price Target to $7.00

Integral Ad Science (NASDAQ:IAS - Get Free Report) had its price objective lowered by stock analysts at Barclays from $14.00 to $7.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an "equal weight" rating on the stock. Barclays's price objective would indicate a potential downside of 1.96% from the stock's current price.

Several other equities analysts have also recently commented on the stock. Scotiabank initiated coverage on shares of Integral Ad Science in a research report on Friday, February 28th. They set a "sector perform" rating and a $12.00 target price on the stock. Truist Financial lifted their price target on Integral Ad Science from $16.00 to $17.00 and gave the stock a "buy" rating in a report on Monday, March 3rd. Benchmark restated a "hold" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Robert W. Baird reiterated a "neutral" rating and set a $9.00 target price (down from $16.00) on shares of Integral Ad Science in a research note on Friday, March 28th. Finally, Oppenheimer reissued an "outperform" rating on shares of Integral Ad Science in a report on Friday, February 28th. Six research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $13.68.

Integral Ad Science Stock Up 3.8 %

Shares of NASDAQ:IAS traded up $0.26 during mid-day trading on Monday, hitting $7.14. 756,991 shares of the company traded hands, compared to its average volume of 1,102,183. The stock has a 50-day moving average price of $8.53 and a two-hundred day moving average price of $9.99. Integral Ad Science has a 12-month low of $6.26 and a 12-month high of $13.62. The stock has a market cap of $1.17 billion, a P/E ratio of 35.70, a P/E/G ratio of 1.06 and a beta of 1.53. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.03). The firm had revenue of $153.00 million for the quarter, compared to analysts' expectations of $148.83 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Integral Ad Science's revenue was up 13.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.06 earnings per share. On average, equities research analysts forecast that Integral Ad Science will post 0.26 earnings per share for the current year.

Insider Transactions at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 8,547 shares of the stock in a transaction dated Monday, April 7th. The shares were sold at an average price of $6.85, for a total value of $58,546.95. Following the sale, the chief executive officer now directly owns 341,271 shares of the company's stock, valued at approximately $2,337,706.35. This represents a 2.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders sold 90,303 shares of company stock valued at $706,660 over the last three months. Company insiders own 2.00% of the company's stock.

Hedge Funds Weigh In On Integral Ad Science

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Integral Ad Science by 2.3% in the 4th quarter. Vanguard Group Inc. now owns 9,048,546 shares of the company's stock valued at $94,467,000 after purchasing an additional 205,562 shares during the period. Alyeska Investment Group L.P. bought a new stake in Integral Ad Science during the fourth quarter valued at $41,543,000. Dimensional Fund Advisors LP grew its position in Integral Ad Science by 18.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock worth $39,567,000 after buying an additional 580,323 shares in the last quarter. Ararat Capital Management LP increased its stake in Integral Ad Science by 13.4% in the 4th quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock worth $23,823,000 after acquiring an additional 269,346 shares during the last quarter. Finally, Nuveen Asset Management LLC raised its holdings in shares of Integral Ad Science by 0.8% in the 4th quarter. Nuveen Asset Management LLC now owns 1,920,523 shares of the company's stock valued at $20,050,000 after acquiring an additional 15,432 shares in the last quarter. Hedge funds and other institutional investors own 95.78% of the company's stock.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.